 |
|||
| Follow us on |  |  |
Sign up for LCFA UPDATES |
|
|||
Welcome to LCFA, the LUNG CANCER FOUNDATION OF AMERICA
The Lung Cancer Foundation of America's mission is to save lives by dramatically increasing the five-year survival rates for all stages of lung cancer, the nation's leading cause of cancer deaths for both men and women. The LCFA will accomplish this by providing the necessary and critical funding for creative and leading edge lung cancer research programs.
ANNOUNCEMENTS
New Lung Cancer Treatment
Get Your Lung Cancer Tumor Tested... Free!
Exciting new research is evolving that can test your lung cancer tumor tissue for specific gene mutations! If you are one of the 28% of lung cancer patients with one of these specific mutations, you can then be matched to a targeted therapy that is specifically linked to your unique tumor mutation. Click here for more information and to see a listing of the 14 institutions that are participating in the Lung Cancer Mutation Consortium Protocol.
"Take a plane, take a train, take a car" and join us "where the surf meets the turf down in old Del Mar." At this LCFA "Day at the Races" charity event, drink, dine, and enjoy the races at Del Mar Race Track featuring a special BreatheLIFE race for LCFA.
Click here to learn more. Click here to purchase tickets.
OPI Re-Introduces BREATHELIFE
Thank you OPI Products, Inc for Re-Introducing BREATHELIFE, a custom designed nail lacquer for LCFA to help "breathe life" into raising funds for the early detection, treatment, and a cure for lung cancer.
Click here to learn more.
 |
 |
| PERSONAL BLOGS |
| LUNG CANCER NEWS |
| EVENTS |
Because of your generous contributions, LCFA is very excited to announce the winners of its first scientific research grant. In partnership with the International Association for the Study of Lung Cancer (IASLC), the LCFA Lung Cancer Research Grant will award $125,000 to Dr. Jessica Donnington at NYU for her research involving the understanding of the role of a specific protein called osteopontin in the growth and metastatic spread of non small cell lung cancer. LCFA will also award $30,000 to Dr. Goeffrey Liu for his study of the genetic differences in patients treated with anti-angiogenic agents to see if he can identify which patients benefit from this therapy. Click here for more information on the LCFA Grant Award winners.